About

Log in?

DTU users get better search results including licensed content and discounts on order fees.

Anyone can log in and get personalized features such as favorites, tags and feeds.

Log in as DTU user Log in as non-DTU user No thanks

DTU Findit

Interpreted as:

title:(Modelling AND the AND glucose-insulin-glucagon AND dynamics AND after AND subcutaneous AND administration AND of AND native AND glucagon AND and AND a AND novel AND glucagon AND analogue AND in AND dogs)

Suggestions: Include records that partially match the query

Filter results
Access
Type
Language
Year
From DTU
Advanced
1 Conference paper

Modelling the glucose-insulin-glucagon dynamics after subcutaneous administration of native glucagon and a novel glucagon analogue in dogs

Year: 2016

Language: English

mdlfbpeico ng k hja
2 Conference paper

Modelling the glucose-insulin-glucagon dynamics after subcutaneous administration of native glucagon and a novel glucagon analogue in dogs

Zealand Pharma has invented a glucagon analogue, ZP-GA-1, with increased stability in liquid formulation for treatment of hypoglycemia. A pharmacodynamic (PD) model is needed to compare ZP-GA-1 with marketed glucagon. We aim to develop a model of the complex glucose-insulin-glucagon dynamics based

Year: 2016

Language: English

dmpb ioncflj gekha
3 Report

PK/PD modelling of glucose-insulin-glucagon dynamics in healthy dogs after a subcutaneous bolus administration of native glucagon or a novel glucagon analogue

satisfactorily for both glucagon and the analogue. Parameter estimates of the PD model were not significantly different between the two compounds. Conclusions The new PK/PD model enables simulations of the glucose-insulin-glucagon dynamics after a SC bolus of glucagon or glucagon analogue. The novel glucagon

Year: 2016

Language: English

bmoafd pnh leijckg

DTU users get better search results including licensed content and discounts on order fees.

Log in as DTU user